These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25451210)

  • 1. Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine.
    Hirose TE; Maluf EM; Rodrigues CO
    J Pediatr (Rio J); 2015; 91(2):130-5. PubMed ID: 25451210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children.
    Ruiz-Contreras J; Picazo J; Casado-Flores J; Baquero-Artigao F; Hernández-Sampelayo T; Otheo E; Méndez C; Del Amo M; Balseiro C;
    Vaccine; 2017 Aug; 35(35 Pt B):4646-4651. PubMed ID: 28711388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of invasive Streptococcus pneumoniae serotypes before and 5 years after the introduction of 10-valent pneumococcal conjugate vaccine in Brazil.
    Brandileone MC; Almeida SCG; Minamisava R; Andrade AL
    Vaccine; 2018 May; 36(19):2559-2566. PubMed ID: 29650385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany.
    Imöhl M; Möller J; Reinert RR; Perniciaro S; van der Linden M; Aktas O
    BMC Infect Dis; 2015 Feb; 15():61. PubMed ID: 25885764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of 10-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children up to two years of age in Brazil.
    Grando IM; Moraes Cd; Flannery B; Ramalho WM; Horta MA; Pinho DL; Nascimento GL
    Cad Saude Publica; 2015 Feb; 31(2):276-84. PubMed ID: 25760162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Four years of universal pneumococcal conjugate infant vaccination in Germany: impact on incidence of invasive pneumococcal disease and serotype distribution in children.
    van der Linden M; Weiß S; Falkenhorst G; Siedler A; Imöhl M; von Kries R
    Vaccine; 2012 Aug; 30(40):5880-5. PubMed ID: 22771186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children.
    von Kries R; Hermann M; Hachmeister A; Siedler A; Schmitt HJ; Al-Lahham A; Reinert RR
    Pediatr Infect Dis J; 2002 Nov; 21(11):1017-23. PubMed ID: 12442022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis-Burkina Faso, 2014-2015.
    Kambiré D; Soeters HM; Ouédraogo-Traoré R; Medah I; Sangaré L; Yaméogo I; Sawadogo G; Ouédraogo AS; Ouangraoua S; McGee L; Srinivasan V; Aké F; Congo-Ouédraogo M; Ky Ba A; Whitney CG; Novak RT; Van Beneden C;
    J Infect; 2018 Mar; 76(3):270-279. PubMed ID: 29253559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Appropriateness of a pneumococcal conjugate vaccine in Brazil: potential impact of age and clinical diagnosis, with emphasis on meningitis.
    Brandileone MC; de Andrade AL; Di Fabio JL; Guerra ML; Austrian R
    J Infect Dis; 2003 Apr; 187(8):1206-12. PubMed ID: 12695999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013.
    Kambiré D; Soeters HM; Ouédraogo-Traoré R; Medah I; Sangare L; Yaméogo I; Sawadogo G; Ouédraogo AS; Hema-Ouangraoua S; McGee L; Srinivasan V; Aké F; Congo-Ouédraogo M; Sanou S; Ba AK; Novak RT; Van Beneden C;
    PLoS One; 2016; 11(11):e0166384. PubMed ID: 27832151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and bacteriological characteristics of invasive pneumococcal disease after pneumococcal 10-valent conjugate vaccine implementation in Salvador, Brazil.
    Leite CR; Azevedo J; Galvão VS; Moreno-Carvalho O; Reis JN; Nascimento-Carvalho C
    Braz J Infect Dis; 2016; 20(1):56-60. PubMed ID: 26706019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of 13-valent pneumococcal conjugate vaccine on laboratory-confirmed pneumococcal meningitis and purulent meningitis among children ˂5 years in Cameroon, 2011-2018.
    Njuma Libwea J; Fletcher MA; Koki Ndombo P; Boula A; Ashukem NT; Ngo Baleba M; Kingue Bebey RS; Nkolo Mviena EG; Tageube J; Kobela Mbollo M; Koulla-Shiro S; Madhi S; Njanpop-Lafourcade BM; Mohammad A; Begier E; Southern J; Beavon R; Gessner B
    PLoS One; 2021; 16(4):e0250010. PubMed ID: 33857235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of 10- and 13-valent pneumococcal conjugate vaccines on incidence of invasive pneumococcal disease in children aged under 16 years in Germany, 2009 to 2012.
    Weiss S; Falkenhorst G; van der Linden M; Imohl M; von Kries R
    Euro Surveill; 2015 Mar; 20(10):21057. PubMed ID: 25788255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continued occurrence of serotype 1 pneumococcal meningitis in two regions located in the meningitis belt in Ghana five years after introduction of 13-valent pneumococcal conjugate vaccine.
    Bozio CH; Abdul-Karim A; Abenyeri J; Abubakari B; Ofosu W; Zoya J; Ouattara M; Srinivasan V; Vuong JT; Opare D; Asiedu-Bekoe F; Lessa FC
    PLoS One; 2018; 13(9):e0203205. PubMed ID: 30192772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive Pneumococcal Disease Following the Introduction of 13-Valent Conjugate Vaccine in Children in New York City From 2007 to 2012.
    Farnham AC; Zimmerman CM; Papadouka V; Konty KJ; Zucker JR; Nattanmai GV; Jose S; Rosen JB
    JAMA Pediatr; 2015 Jul; 169(7):646-52. PubMed ID: 25938798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000-June 30, 2016.
    Oligbu G; Collins S; Djennad A; Sheppard CL; Fry NK; Andrews NJ; Borrow R; Ramsay ME; Ladhani SN
    Emerg Infect Dis; 2019 Sep; 25(9):1708-1718. PubMed ID: 31441745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pneumococcal Meningitis Vaccine Breakthroughs and Failures After Routine 7-Valent and 13-Valent Pneumococcal Conjugate Vaccination in Children in France.
    Godot C; Levy C; Varon E; Picard C; Madhi F; Cohen R
    Pediatr Infect Dis J; 2015 Oct; 34(10):e260-3. PubMed ID: 26181894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of the 13-valent pneumococcal conjugate vaccine on the incidence of pneumococcal meningitis in children.
    Chapoutot AG; Dessein R; Guilluy O; Lagrée M; Wallet F; Varon E; Martinot A; Dubos F
    Epidemiol Infect; 2016 Feb; 144(3):607-11. PubMed ID: 26234410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumococcal meningitis in Cantabria (Spain) in the pneumococcal conjugate vaccine era (2001-2015).
    González-Escartín E; Angulo López I; Ots Ruiz E; Martínez-Martínez L; Cabero Pérez MJ
    Arch Argent Pediatr; 2017 Apr; 115(2):160-164. PubMed ID: 28318182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.